These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7546930)

  • 1. [Approach to human glioma cells using antisense molecules].
    Yoshida S; Tanaka R
    No To Shinkei; 1995 Sep; 47(9):823-8. PubMed ID: 7546930
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2)].
    Nitta T
    No Shinkei Geka; 1994 Oct; 22(10):903-9. PubMed ID: 7969756
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific gene suppression using antisense strategy for growth suppression of glioma.
    Matsuno A; Nagashima T
    Med Electron Microsc; 2004 Sep; 37(3):158-61. PubMed ID: 15449107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
    Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
    Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
    Laird AD; Brown PI; Fausto N
    Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
    Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
    Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of glioma using cytokine].
    Ikeda H; Yoshida J
    No To Shinkei; 1995 Sep; 47(9):835-43. PubMed ID: 7546932
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biology and gene therapy of glioma].
    Sanson M; Hoang-Xuan K
    Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors.
    Rubenstein M; Tsui P; Guinan P
    Med Hypotheses; 2005; 65(5):905-7. PubMed ID: 16023790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy for brain tumors: induction of apoptosis and immunogenic modulation in glioma cells (series 5)].
    Asai A
    No Shinkei Geka; 1995 Jan; 23(1):7-15. PubMed ID: 7845524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of myelin basic protein gene promoter for the gene therapy of malignant glioma].
    Miyao Y; Shimizu K; Hayakawa T; Mikoshiba K
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2618-23. PubMed ID: 8584710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental research of gene therapy for human gliomas with vascular endothelial growth factor(165) antisense RNA].
    Zhang X; Wu J; Gao D
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):386-8. PubMed ID: 11798792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for malignant glioma: current clinical status.
    Pulkkanen KJ; Yla-Herttuala S
    Mol Ther; 2005 Oct; 12(4):585-98. PubMed ID: 16095972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
    Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
    Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential confounding features in p53 gene therapy of recurrent glioma.
    Weil RJ
    J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789
    [No Abstract]   [Full Text] [Related]  

  • 19. New innovations and developments for glioma treatment.
    Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
    Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
    [No Abstract]   [Full Text] [Related]  

  • 20. Radio-responsive TRAIL gene therapy for malignant gliomas.
    Kyritsis AP; Rao JS; Puduvalli VK
    Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.